Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001209191-21-053304

Options or other derivatives

  • Chief Medical Officer acquired 150,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

KENNEY CHRISTOPHER JOHN · Chief Medical Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-08-23 Grant or award : show line 1 in the form Stock Option (Right to Buy) +150,000 150,000 D
Loading xslF345X03/doc4.xml…